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Abstract
Background: The present study describes the clinical features and plasma profiles of bovine
pregnancy-associated glycoprotein 1 (bPAG1), the main metabolite of prostaglandin F2α (PG
metabolite) and progesterone (P4) in heifers in which early abortions were induced.
Methods: Early abortions were induced in four heifers with cloprostenol and monitored by
ultrasonography. Blood samples were collected and the plasma were analyzed for bPAG 1, P4 and
PG metabolite.
Results: The foetal heartbeat rates varied from 170–186 beats per minute for all foetuses up to
the date of cloprostenol treatment. Foetal death was confirmed within two days after cloprostenol
treatment. Prior to cloprostenol injection, blood plasma concentrations of bPAG1, PG metabolite
and P4 varied from 8.4 – 40.0 ng/mL, 158 – 275 pmol/L and 20.7 – 46.9 nmol/L, respectively. After
the foetus expelled, the plasma level of bPAG1 began to decrease but the decrease was small and
gradual. The estimated half-life of bPAG1 was 1.8 – 6.6 days. The plasma level of the PG metabolite
started to have short lasting peaks (above 300 pmol/L) within three hours after cloprostenol
treatment. The plasma concentrations of P4 dropped sharply to less than 4 nmol/L after 24 hours
of cloprostenol injection.
Conclusion: The current findings indicated that after early closprostenol-induced foetal death, the
plasma concentration of bPAG1 decreased gradually and showed a tendency of variation with the
stages of pregnancy.
Background
The isolation and characterization of pregnancy-specific
protein B (PSPB) [1] or bovine pregnancy-associated glyc-
oprotein 1 (bPAG1)[2] in the cow by immunoelectro-
phoresis and the subsequent development of RIA
techniques for this protein (for PSPB[3] and for
bPAG1[4]) enabled hormonal diagnosis of pregnancy in
cattle. Detection of PSPB/bPAG1 in the maternal blood
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can be a good indicator of pregnancy and foeto-placental
viability [5,6]. PSPB/bPAG1 is detected at around 24 days
post conception and reaches a peak at approximately the
time of parturition and drops after calving but it is detect-
able for up to 3 months in postpartum cows [3,4,7].
In early (between 30–50 days of pregnancy) abortions
induced both by experimental Arcanobacterium pyogens
infection and by natural prostaglandin F2α, the plasma
concentration of PSPB fell steadily from the day of inocu-
lation/treatment but the levels remained above the
threshold with a half-life time of 7 days. In terms of
detecting embryonic loss following infection, monitoring
PSPB on a regular basis has advantages over the assess-
ment of progesterone concentration [5]. Thus PSPB/
bPAG1 analysis could be used as an alternative test to
determine pregnancy after 30 days post breeding but its
relative long half-life (7–8 days, [5,8]), imposes limita-
tions especially in post partum cows and in cows after
embryonic/foetal mortality.
In cloprostenol induced early abortions in heifers, the
clinical features and patterns of prostaglandin F2α metab-
olite (PG metabolite) were categorized into two: after 100
days and before 75 days of pregnancy stages [9]. The heif-
ers in the former group had retained foetal membranes
and delayed return to cyclicity and heat whereas heifers in
the latter group expelled their foetuses with intact foetal
membranes and showed standing heat within three days
after injection. Although most pregnancy failures occur
due to embryonic/early foetal mortality up to 50 days post
breeding, foetal mortality occurs to some extent until 90
days of pregnancy [10,11]. Detailed information about
clinical features and plasma profiles of PSPB/bPAG1 and
PG metabolite after induced or spontaneous foetal mor-
tality for pregnancy stages after 60 days (for PSPB/bPAG1)
and between 75–90 days (for PG metabolite) in cattle is
sparse.
Accurate pregnancy diagnosis could be achieved based on
the recognition of a proper embryo with a beating heart,
between 26 and 34 days, by use of ultrasonography in cat-
tle [12]. Moreover, embryonic mortality could be esti-
mated at an earlier stage by ultrasound investigation than
by PSPB or progesterone assays [5,13]. Thus ultrasound
could be used to monitor embryonic/foetal viability and
consequently to determine the time of embryo/foetal
mortality in induced or spontaneous abortions in cattle.
Therefore, the present study describes the clinical features
and plasma profiles of bPAG1, PG metabolite and proges-
terone in heifers after cloprostenol induced early abor-
tions (between 60 and 120 days of pregnancy) monitored
by ultrasonography.
Methods
Experimental animals
Four Swedish Red and White Breed (SRB) heifers (num-
bered 1–4) were used. The first three heifers were 24
months old while the fourth one was 21 months old at the
beginning of the experiment. They were fed according to
the Swedish standard and their rectal temperature and
clinical status were regularly checked. The experiment was
done, with the approval of the local ethical committee, at
the Department of Clinical Sciences, Swedish University
of Agricultural Sciences, Uppsala.
Experimental protocol
Heifers were inseminated following standing heat. Heifer-
4 conceived on the first insemination whereas heifers 2
and 3 on the second and heifer-1 on the third consecutive
inseminations. A transrectal ultrasonography (5 MHz lin-
ear array transducer; Aloka SSD-210 DXII, Aloka Co.,
Tokyo, Japan) was used to confirm pregnancy and moni-
tor embryo/foetal viability. Embryo/foetus viability was
monitored once weekly until 7 days before cloprostenol
treatment and then daily till foetal death/abortion
occurred. Heartbeat rate was determined by counting the
number of heartbeats from the video tape recording of the
ultrasonographic examinations as described previously
[14]. The heifers were given one intramuscular injection
of 500 μg of a prostaglandin analogue (cloprostenol,
Estrumate®, Schering-Plough, Stockholm, Sweden) to
induce luteolysis and subsequent foetal death and abor-
tion. At the time of cloprostenol treatment, heifers 1, 2, 3
and 4 were at pregnancy stages of 63, 77, 83 and 116 days,
respectively.
Blood samples were collected from the jugular vein start-
ing one week before cloprostenol treatment. The collec-
tion was performed by venipuncture every day for the first
five days followed by every three hours from two days
before until five days post cloprostenol treatment. Two
further blood samples were collected on the 7th and 9th
days post cloprostenol injection. The blood samples were
drawn into heparinized vacuum tubes and centrifuged
immediately. The plasma was removed and stored at -
20°C until analysed.
Hormone analysis
Those plasma samples collected two days before and fives
days post cloprostenol treatment were analysed for PG
while the daily (the first five days and the last two days)
and every six hours (two days before and five days post
cloprostenol treatment) plasma samples were analysed
for P4 and bPAG1. The Plasma samples were analyzed for
concentrations of progesterone [15] and PG metabolite
[16] according to the radioimmunoassay methods previ-
ously described. Whereas bPAG1 analysis was done fol-
lowing the techniques initially described [4] with littleActa Veterinaria Scandinavica 2006, 48:23 http://www.actavetscand.com/content/48/1/23
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modification as described briefly hereunder. As an assay
buffer 25 mM Tris HCl, pH 7.6 + 0.1% bovine serum albu-
min was used throughout the procedure. Bovine 125I-PAG
labelled according to the chloramine T method [17] was
used as a tracer. Antiserum raised in rabbit against bPAG1
was used as the first antibody at an initial dilution of
1:150,000 whereas double antibody precipitation system
was used to separate the bound complex.
For the standard curve lyophilized bPAG1 was diluted
with assay buffer to get concentrations ranging from 0.78
to 100 ng/mL in a non-preincubated system. Of each
standard concentration, 0.1 mL was added to duplicate
tubes and diluted with 0.2 mL assay buffer and for the
zero standards (B0) and non-specific binding (NSB), only
0.3 and 0.4 mL of buffer, respectively was added. Bovine
PAG free serum (0.1 mL) was added to all standard curve
tubes. For the test plasma samples, duplicate tubes were
labelled for each sample and 0.3 mL assay buffer was
added to each tube including two more duplicate tubes
for quality control. Then 0.1 mL of each test plasma sam-
ple and the two quality control sera was added to the
respective duplicate tubes. Following this, 0.1 mL of tracer
and first antibody were consecutively added to all tubes
(except the first antibody for non-specific binding tubes)
and mixed gently and incubated overnight at room tem-
perature. A tracer (0.1 mL) alone was added to duplicate
tubes for total count (T). The second day, 1 mL of the dou-
ble antibody precipitation system was added to all tubes
except the T and incubated for further 30 minutes. After
dilution with 2 mL of assay buffer, all tubes were centri-
fuged at 1500 × g for 20 minutes and the radioactivity of
the pellet (discarding the supernatants) was counted by a
gamma counter (LKB Wallac 1261; Wallac Turku, Fin-
land) with a counting efficiency of 75%. The binding ratio
of the radiolabelled 125I-PAG to the antiserum was consid-
ered as 100% in the zero standard (B0) assay tube.
The sensitivity of the bPAG1 RIA was 1 ng/mL for the non-
preincubated system used. The intra-assay CV for two
serum samples with known bPAG1 concentrations (mean
± SD = 2.5 ± 0.3 and 29.3 ± 2.3 ng/mL) each carried out
twenty times were 10.8% and 8.2%, respectively. While
the inter-assay CV of low and high concentrations of
bPAG1 quality control serum pools (mean ± SD = 9.2 ±
0.4 and 50.3 ± 3.0 ng/mL) were 4.5 and 6.0%, respec-
tively.
Determination of half-life for bPAG1
Half-life for bPAG1 was estimated for the first three heif-
ers and the fourth one starting from 2.3 and 4 days post
cloprostenol injection, respectively, at which the fall in
plasma bPAG1 concentration was commenced. The fol-
lowing formula was employed [8,18] for the estimation.
T1/2 = [ln(C/.5C)]/λ
Where C is the plasma concentration of bPAG1 at time
zero, and λ is the slope of the regression equation.
Results
Clinical and ultrasonographic features
Pregnancy was confirmed between 33 and 40 days post-
insemination by detection of heartbeat of the embryo.
The foetal heartbeat rates varied from 170–186 beats per
minute for all foetuses up to the date of cloprostenol treat-
ment. Foetal death (loss of heartbeat) was confirmed
within two days after cloprostenol treatment. Two of the
heifers (nos. 1 & 2) had thick mucous vaginal discharge
whereas the other two had blood tinged discharge on the
second day post cloprostenol treatment. The dead foe-
tuses were expelled within four days after cloprostenol
treatment in three of the heifers whereas the fourth was
trapped in the vagina and removed manually. There was
no grossly visible abnormality in aborted foetuses at
necropsy examination. Standing oestrus was observed in
two of the heifers (nos. 1 & 2) within two days after abor-
tion. The detailed clinical and ultrasonographic features
associated with cloprostenol induced early abortions are
summarised in Table 1.
Plasma hormonal profiles
During one week prior to cloprostenol injection, the
plasma concentrations of bPAG1, PG metabolite and pro-
gesterone varied from 8.4 – 40.0 ng/mL, 158 – 275 pmol/
L and 20.7 – 46.9 nmol/L, respectively. The plasma
bPAG1 concentrations were progressively increasing with
minor irregularities in heifers 1 and 3 while the changes
were irregular in the other two heifers during the one-
week period of blood sampled until cloprostenol treat-
ment. Between cloprostenol treatment and expulsion of
foetus, the plasma bPAG1 level did not fall but showed
minor changes. After foetal expulsion, the plasma level of
bPAG1 began to decrease but the decrease was small and
gradual up to the last blood sample analysed (6–7 days
after foetal expulsion). This decrease in plasma concentra-
tions of bPAG1 was 65.3%, 57.5%, 55.3% and 45.6% for
heifers 1–4, respectively. The rate of decrease seems rela-
tively slower with increasing pregnancy stage at the time
of cloprostenol injection. On the basis of gradual decline
of the plasma levels of bPAG1, a half-life ranging from 1.8
– 6.6 days was estimated.
The plasma level of PG metabolite started to have short
lasting peaks (above 300 pmol/L) within three hours after
cloprostenol treatment. Then it returned to the pre-treat-
ment level after foetal mortality in the first two heifers (see
Fig. 1 &2) but the pulsatile release (above 300 pmol/L) of
PG metabolite continued up to the last blood sample ana-
lysed (5th day post cloprostenol injection) in the other two
heifers especially in the fourth heifer (see Fig. 3 &4).Acta Veterinaria Scandinavica 2006, 48:23 http://www.actavetscand.com/content/48/1/23
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The plasma concentration of progesterone dropped
sharply after the cloprostenol injection and was less than
4 nmol/L after 24 hours in all heifers. From the last
plasma sample analysed, the progesterone concentration
seems to rise again in the first three heifers (see Fig. 1, 2,
3) indicating resumption of ovarian cyclicity but it
remained below detection in the fourth heifer (see Fig. 4).
Discussion
Because of the unpredictable occurrence of embryonic or
foetal losses in a herd and the current increasing interest
Plasma profiles of bPAG1, P4 & PG for Heifer-1 before and after cloprostenol treatment on day 0 (63 days post insemination).  Foetal death occurred between the two arrows Figure 1
Plasma profiles of bPAG1, P4 & PG for Heifer-1 before and after cloprostenol treatment on day 0 (63 days 
post insemination). Foetal death occurred between the two arrows. P4 = progesterone; bPAG1 = bovine pregnancy 
associated glycoprotein 1; PG = the main metabolite of prostaglandin F2α
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Table 1: Clinical and ultrasonographic features associated with cloprostenol induced early abortions in four Swedish Red and White 
heifers.
Clinical/Ultrasonographic Features Heifer-1 Heifer-2 Heifer-3 Heifer-4
Stages of gestation* (days) 63 77 83 116
Heartbeat rate (beats per minute) 170–182 178–186 180–184 176–182
Foetal death post-CP treatment (Hrs) < 24 < 24 24 – 48 24 – 48
Foetus/FM expelled** (Hrs) 56 – 72 80 – 96 75 80 – 96#
CRL of expelled foetus (cm) 9 12 15 30
Foetus expelled with unruptured FM Yes Yes Yes No#
Thick mucous vaginal discharge Yes Yes No No
Blood tinged vaginal discharge No No Yes Yes
Showed standing heat*** Yes Yes No No
*on the day of cloprostenol treatment; **after cloprostenol treatment; ***within two days after abortion; #only the foetal membrane was expelled 
but the foetus was stacked in the vagina and removed manually; CP = cloprostenol; Hrs = hours; CRL = crown-rump length; FM = foetal membrane.Acta Veterinaria Scandinavica 2006, 48:23 http://www.actavetscand.com/content/48/1/23
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of monitoring pregnancies in bovine, it is important to
monitor pregnancies at early stage. One way to create a
model of foetal death is to use drugs like cloprostenol that
induce mortality.
Lindell and co-workers [9] induced abortions in heifers
and found differences on physical nature of the abortions
and PG metabolite release between two different stages of
pregnancies (pregnancies below 75 days and between 100
– 150 days). In the former group foetuses were delivered
with intact foetal membranes with little or no bleeding
whereas in the latter group the aborted foetuses were
delivered prior to the membranes, which were retained for
more than 24 hours. The proposed reason for the differ-
ences in the nature of the induced abortions was the dif-
ferences in the degree of foetal membrane attachment.
The findings of the present study are in agreement with
the report of Lindell and co-workers [9], but heifer no. 3
is obviously falling between the two groups since she had
blood tinged vaginal discharge and expelled foetus with
intact foetal membrane.
Standing oestrus was observed in two of the heifers (nos.
1 & 2) within two days after abortion supporting the sug-
gestion given by Lindell and co-workers [9]. These authors
suggested that abortion could be induced up to 80 days of
pregnancy for practical reasons with little or no compro-
mise at the subsequent reproductive performance at least
in heifers. This is because such abortions are associated
with only little or no uterine trauma. This idea is further
supported by the return of PG metabolite release to the
basal level immediately after abortion in these heifers
Plasma profiles of bPAG1, P4 & PG for Heifer-2 before and after cloprostenol treatment on day 0 (77 days post insemination).  Foetal death occurred between the two arrows Figure 2
Plasma profiles of bPAG1, P4 & PG for Heifer-2 before and after cloprostenol treatment on day 0 (77 days 
post insemination). Foetal death occurred between the two arrows. P4 = progesterone; bPAG1 = bovine pregnancy 
associated glycoprotein 1; PG = the main metabolite of prostaglandin F2α
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unlike those heifers above 100 days of pregnancy as it was
observed by Lindell and co-workers [9] and the current
study.
Detection of PSPB or bPAG1 above the threshold levels in
the maternal blood of cows or heifers is a good indicator
of the presence of a live embryo or foetus with the excep-
tions during the postpartum period or for few days after
embryonic/foetal death [5,6]. Moreover, the plasma/
serum levels of PSPB/bPAG1 fell steadily commencing
within 24 hours of inoculation/injection [5] or embry-
onic/foetal mortality [18] following experimental Arcano-
bacterium pyogens infection or cloprostenol injection. On
the other hand, in the current study the gradual fall of
plasma bPAG1 concentration commenced after 48 hours
of cloprostenol treatment (after expulsion of the foetuses)
in three of the heifers and even later in the fourth heifer.
The previous experiments involved heifers/cows at preg-
nancy stages less than 50 days whereas the current one
above 60 days, which may explain the observed difference
in the time of start of decline in plasma bPAG1 concentra-
tion. Szenci and co-workers [18] reported a half-life of 3.2
– 3.9 days of bPAG1 after cloprostenol induced embry-
onic mortality in heifers, which falls within the range of
the current finding. Moreover, Semambo and co-workers
[5] reported approximately seven days half-life of PSPB,
which is roughly closer to the present finding. The minor
differences observed in the half-life of bPAG1 among the
reports of different workers may be due to differences in
the stages of pregnancy at the time of induction of embry-
onic/foetal mortality. In the current study the plasma level
of bPAG1 did not fall immediately after death of the foe-
tus but it showed minor changes until the foetus was
expelled. These minor changes in plasma bPAG1 concen-
Plasma profiles of bPAG1, P4 & PG for Heifer-3 before and after cloprostenol treatment on day 0 (83 days post insemination).  Foetal death occurred between the two arrows Figure 3
Plasma profiles of bPAG1, P4 & PG for Heifer-3 before and after cloprostenol treatment on day 0 (83 days 
post insemination). Foetal death occurred between the two arrows. P4 = progesterone; bPAG1 = bovine pregnancy 
associated glycoprotein 1; PG = the main metabolite of prostaglandin F2α
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tration could be possibly explained by the effect of uterine
contraction caused by the pulsatile release of the endog-
enous PGF2α (measured as the metabolite) and a continu-
ity of the placental release of bPAG1 for a brief time even
after foetal death. Moreover, the differences in the rate of
decline of plasma bPAG1 concentration observed among
the heifers at different stages of gestation period could
also be possibly attributed to the increase in the plasma
concentration and half-life of the glycoprotein with
increasing stage of pregnancy.
The plasma PG metabolite level before cloprostenol treat-
ment was in the basal level (below 300 pmol/L) but the
level increased immediately after the treatment, which
agrees with the results of Lindell and co-workers [9]. How-
ever, the reason behind such immediate rise of the periph-
eral blood level of endogenous PG metabolite after
cloprostenol injection is not well established and it needs
further investigation.
In heifer no. 4, the pulsatile release of PG metabolite con-
tinued up to five days post PG injection even after expul-
sion of the foetus though the highest concentration of PG
metabolite was 623 pmol/L. This plasma PG metabolite
concentration is low as compared to the previous report of
Lindell and co-workers [9], who reported massive release
of PG metabolite up to 2500 pmol/L in heifers having the
same pregnancy stage (heifer no. 4) at the time of abor-
tion induced by cloprostenol. This difference in the level
of PG metabolite could be partly attributed to the effect of
Plasma profiles of bPAG1, P4 & PG for Heifer-4 before and after cloprostenol treatment on day 0 (116 days post insemination).  Foetal death occurred between the arrows Figure 4
Plasma profiles of bPAG1, P4 & PG for Heifer-4 before and after cloprostenol treatment on day 0 (116 days 
post insemination). Foetal death occurred between the arrows. P4 = progesterone; bPAG1 = bovine pregnancy asso-
ciated glycoprotein 1; PG = the main metabolite of prostaglandin F2α
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retained foetal membranes in case of the latter heifer with
higher level of PG metabolite. This is because cows with
retained foetal membranes had significantly higher levels
of PG metabolite than cows without retained foetal mem-
branes during the immediate postpartum period [19].
In the current study, a sharp decline of plasma levels of
progesterone (from above 20.7 nmol/L to less than 4
nmol/L) during 24 hours post cloprostenol injection was
observed. This finding agrees with previous reports that
indicated the luteolytic effect of cloprostenol in cyclic
non-pregnant or pregnant cows/heifers [9,20-22]. In the
present study, the disruption of foeto-endometrial con-
nection as a result of contraction of the uterus caused by
the pulsatile release of the endogenous PG metabolite
could be the possible cause for the occurrence of foetal
deaths within 24 to 48 hours after cloprostenol injection.
Szenci and co-workers [18] reported the occurrence of late
embryonic mortalities within 24 and between 48 and 72
hours post Arcanobacterium pyogens inoculation and clo-
prostenol treatment, respectively. In another cloprostenol
induced abortion study, the progesterone concentration
dramatically declined to < 0.5 ng/mL within 24 hours of
treatment [5].
Conclusion
In conclusion, the results of the present study indicated
that after early closprostenol-induced foetal death (at
pregnancy stages between 60 and 120 days) the plasma
concentration of bPAG1 decreased gradually and the rate
of decrease showed a tendency of variation with the stages
of pregnancy, which requires further confirmation. More-
over, the current finding supports the suggestion [9] that
abortion could be successfully induced up to 80 days of
pregnancy for practical reasons at least in heifers with little
or no compromise to the subsequent reproductive per-
formance.
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